COSCIENS Biopharma Correlations

CSCI Stock

2.92 0.21 6.71%

The current 90-days correlation between COSCIENS Biopharma and Boston Omaha Corp is -0.04 (i.e., Good diversification). The correlation of COSCIENS Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

COSCIENS Biopharma Correlation With Market

Good diversification

The correlation between COSCIENS Biopharma and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding COSCIENS Biopharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in COSCIENS Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.

Moving together with COSCIENS Stock

0.85	ME	23Andme Holding	Pair Corr
0.83	VALN	Valneva SE ADR	Pair Corr
0.63	DNTH	Dianthus Therapeutics	Pair Corr
0.7	DOMH	Dominari Holdings	Pair Corr
0.79	DRMA	Dermata Therapeutics	Pair Corr
0.81	DRRX	Durect	Pair Corr
0.89	DTIL	Precision BioSciences Downward Rally	Pair Corr
0.78	VINC	Vincerx Pharma	Pair Corr
0.85	VIRX	Viracta Therapeutics	Pair Corr
0.75	VRCA	Verrica Pharmaceuticals	Pair Corr
0.74	VTGN	VistaGen Therapeutics	Pair Corr

Moving against COSCIENS Stock

0.81	VCYT	Veracyte	Pair Corr
0.74	SABSW	SAB Biotherapeutics	Pair Corr
0.71	VCEL	Vericel Corp Ord	Pair Corr
0.71	VERA	Vera Therapeutics	Pair Corr
0.63	DRUG	Bright Minds Biosciences Trending	Pair Corr
0.55	VANI	Vivani Medical	Pair Corr
0.44	DSGN	Design Therapeutics	Pair Corr
0.34	DMAC	DiaMedica Therapeutics Downward Rally	Pair Corr
0.82	VSTM	Verastem Trending	Pair Corr
0.81	VRNA	Verona Pharma PLC	Pair Corr
0.81	VTRS	Viatris	Pair Corr
0.72	DVAX	Dynavax Technologies	Pair Corr
0.43	DYAI	Dyadic International	Pair Corr

Related Correlations Analysis

	BOC	KDP	TBVPY	WIMI	CSXXY	COCO	SNDL	STBFY
BOC		-0.44	0.0	0.08	0.06	0.65	0.25	-0.54	BOC
KDP	-0.44		0.0	0.24	-0.05	-0.84	0.0	0.88	KDP
TBVPY	0.0	0.0		0.0	0.0	0.0	0.0	0.0	TBVPY
WIMI	0.08	0.24	0.0		-0.17	-0.1	0.01	0.15	WIMI
CSXXY	0.06	-0.05	0.0	-0.17		0.02	0.15	0.03	CSXXY
COCO	0.65	-0.84	0.0	-0.1	0.02		-0.04	-0.8	COCO
SNDL	0.25	0.0	0.0	0.01	0.15	-0.04		0.03	SNDL
STBFY	-0.54	0.88	0.0	0.15	0.03	-0.8	0.03		STBFY
	BOC	KDP	TBVPY	WIMI	CSXXY	COCO	SNDL	STBFY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

STBFY	+ 0.88	KDP
COCO	+ 0.65	BOC
SNDL	+ 0.25	BOC
WIMI	+ 0.24	KDP
STBFY	+ 0.15	WIMI
SNDL	+ 0.15	CSXXY

High negative correlations

COCO	- 0.84	KDP
STBFY	- 0.8	COCO
STBFY	- 0.54	BOC
KDP	- 0.44	BOC
CSXXY	- 0.17	WIMI
COCO	- 0.1	WIMI

Risk-Adjusted Indicators

There is a big difference between COSCIENS Stock performing well and COSCIENS Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze COSCIENS Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BOC	1.07	(0.03)	(0.01)	0.10	1.56	(1.02)	1.91	(2.39)	8.78
KDP	0.76	(0.20)	0.00	(0.36)	0.00	0.00	1.46	(2.08)	6.67
TBVPY	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
WIMI	3.34	0.10	0.02	0.25	4.13	(4.15)	8.42	(6.33)	26.90
CSXXY	1.22	0.11	0.00	0.56	1.68	(4.15)	6.22	(5.22)	16.82
COCO	1.59	0.48	0.20	1.20	1.47	(1.77)	3.72	(3.13)	11.39
SNDL	1.94	0.09	(0.02)	(0.14)	3.01	(2.19)	3.86	(3.62)	24.46
STBFY	1.13	(0.05)	0.00	0.36	0.00	0.00	1.93	(2.71)	5.47

COSCIENS Biopharma Corporate Executives

Elected by the shareholders, the COSCIENS Biopharma's board of directors comprises two types of representatives: COSCIENS Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of COSCIENS. The board's role is to monitor COSCIENS Biopharma's management team and ensure that shareholders' interests are well served. COSCIENS Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, COSCIENS Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.

Giuliano Fratta

Senior CFO

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC